Nuclear Cardiology Markets

Table of Contents

1. Overview

• 1.1 Objectives
• 1.2 Scope
• 1.3 Methodology
• 1.4 Executive Summary

2. Medical Imaging Market Analysis

• 2.1 Medical Imaging Industry Market Size
• 2.2 Medical Imaging Infrastructure
  • 2.2.1 Total Healthcare Expenditures and Demographics
  • 2.2.2 Number of Hospitals
  • 2.2.3 Number of Radiologists
  • 2.2.4 Radiology Services
  • 2.2.5 Medical Imaging Companies
  • 2.2.6 Market Drivers
    • 2.2.6.1 Product Enhancements
    • 2.2.6.2 Contrast Agents Development
    • 2.2.6.3 Innovation
  • 2.2.7 Market Restraints
  • 2.2.8 Market Segments for Medical Imaging
    • 2.2.8.1 Discovery
    • 2.2.8.2 Clinical Applications
    • 2.2.8.3 Clinical Trials
    • 2.2.8.4 Outpatient Facilities
    • 2.2.8.5 Technology Advances in Diagnostic Imaging Modalities
    • 2.2.8.6 Safety and Ergonomics Concerns
    • 2.2.8.7 Volumetric Imaging
    • 2.2.8.8 Digital Radiography (DR)
    • 2.2.8.9 Contrast Media

3. Nuclear Medicine and Nuclear Cardiology Market

• 3.1 Medical Imaging Industry Forecasts
• 3.2 Hardware Companies (Nuclear Medicine Instrumentation)
• 3.3 Software Companies (Image Processing and PACS)
• 3.4 Radiopharmaceuticals and Pharmaceuticals Companies
• 3.5 Ancillary Products Companies
• 3.6 Service and Support Companies
• 3.7 Nuclear Cardiology Market
• 3.8 Hardware (PET, SPECT and Hybrids)
  • 3.8.1 Scanner Investment: Not Just a Cardiology Market
    • 3.8.1.1 Impact of Alzheimer' s Reimbursement
  • 3.8.2 Sales Trends for PET Scanners
  • 3.8.3 Market Consolidation in the U.S.
  • 3.8.4 Learning Curve Impact for PET
  • 3.8.5 Hardware Market Trends
• 3.9 Software (PACS and RIS)
• 3.10 Radiopharmaceuticals
  • 3.10.1 Diagnostic Radiopharmaceuticals
  • 3.10.2 Therapeutic Radiopharmaceuticals

4. Products Analysis

• 4.1 Nuclear Medicine Instrumentation
  • 4.1.1 PET Scan
  • 4.1.2 SPECT Scan
    • 4.1.2.1 Heart Imaging
  • 4.1.3 PET Versus SPECT
  • 4.1.4 Hybrid Technology
• 4.2 Image Processing: PACS
  • 4.2.1 PACS and Nuclear Medicine
  • 4.2.2 Difficulties in Making PACS Work with Nuclear Medicine
    • 4.2.1.2 3-D and Quantitative Analysis
    • 4.2.1.5 Small Market Opportunities
• 4.3 Radiopharmaceuticals and Pharmaceuticals
  • 4.3.1 Introduction
  • 4.3.2 Background
  • 4.3.3 Areas of Current Interest

5. Regulations, Reimbursements and Other Issues

• 5.1 Food and Drug Administration (FDA)
  • 5.1.1 FDA Guidance
  • 5.1.2 FDA Nuclear Medicine Coalition
• 5.2 U.S. Nuclear Regulatory Commission (NRC)
  • 5.2.1 What NRC Regulates
  • 5.2.2 How NRC Regulates
  • 5.2.3 Related Information
• 5.3 Memorandum of Understanding between NRC and FDA
  • 5.3.1 Authorities and Regulatory Programs
• 5.4 Current NRC Issues and Actions
  • 5.4.1 Meetings
  • 5.4.2 Program and Policy Issues
  • 5.4.3 Recently Issued Significant Enforcement Actions
    • 5.4.3.1 Stark II Regulations
    • 5.4.3.2 Recent Impact of Stark II Regulations
    • 5.4.3.3 Reimbursement

6. Business Affairs (Mergers, Acquisitions and Partnerships)

• 6.1 Recent Corporate Partnerships and Mergers
• 6.2 Recent Industry Activity
• 6.3 Product Launches and Developments

7. Technology Trends

• 7.1 Hardware (Nuclear Medicine Instrumentation)
• 7.2 Software (PACS)
  • 7.2.1 Problems Interfacing PACS and NM
  • 7.2.2 SNM and IHE
  • 7.2.3 IHE Nuclear Medicine Profile
  • 7.2.4 What Next?
  • 7.2.5 Optimal Patient Care
  • 7.2.6 Four Steps to Standards Adoption
  • 7.2.7 Technical Framework: Business with Technology
  • 7.2.8 Leading by Example
  • 7.2.9 IHE and Electronic Health Record (EHR)
• 7.3 Radiopharmaceuticals and Pharmaceuticals
  • 7.3.1 Market Share
  • 7.3.2 Contrast Media Market Drivers
  • 7.3.3 Contrast Media Market Sector Overview
  • 7.3.4 Contrast Media Market Analysis
  • 7.3.5 Growth Prospects for Contrast Media
• 7.4 Market Sector Analysis
• 7.5 Leading Companies in General Medical Imaging

8. Company Profiles

• 8.1 Hardware (Nuclear Medicine Instrumentation)
  • 8.1.1 AccuSync Medical Research
  • 8.1.2 Bristol-Myers Squibb (Medical Imaging)
  • 8.1.3 Capintec
  • 8.1.4 CardiArc
  • 8.1.5 Cardinal Health (Cardiology Solutions)
  • 8.1.6 Digirad
  • 8.1.7 GE Healthcare
  • 8.1.8 GVI Medical Devices
  • 8.1.9 Hitachi Medical Systems America
  • 8.1.10 IS2 Medical Systems
  • 8.1.11 Mediso
  • 8.1.12 Philips Medical
  • 8.1.13 Positron
  • 8.1.14 Siemens Medical
  • 8.1.15 Spectrum Dynamics
• 8.2 Software (Image Processing and PACS)
  • 8.2.1 Heartlab
  • 8.2.2 Hermes Medical Solutions
  • 8.2.3 INVIA
  • 8.2.4 McKesson
  • 8.2.5 MedImage
  • 8.2.6 MIMvista
  • 8.2.7 Numa
  • 8.2.8 ProSolv Cardiovascular
  • 8.2.9 Scientific Imaging
  • 8.2.10 Segami Corporation
  • 8.2.11 Syntermed
  • 8.2.12 Thinking Systems Corporation
  • 8.2.13 UltraSPECT
  • 8.2.14 Witt Biomedical Corporation
• 8.3 Radiopharmaceuticals and Pharmaceuticals
  • 8.3.1 Astellas Pharma U.S.
  • 8.3.2 Bracco Diagnostics
  • 8.3.3 Isotope Products Laboratories
  • 8.3.4 Izotop: Institute of Isotopes
  • 8.3.5 Mallinckrodt
  • 8.3.6 Merck
  • 8.3.7 NuView Radiopharmaceuticals
  • 8.3.8 Pfizer
  • 8.3.9 Tyco Healthcare
• 8.4 Ancillary Products
  • 8.4.1 CNMTStore.com
  • 8.4.2 Data Spectrum Corporation
  • 8.4.3 Daxor Corporation
  • 8.4.4 Ivy Biomedical Systems
  • 8.4.5 MarCal Medical
• 8.5 Service and Support
  • 8.5.1 BC Technical
  • 8.5.2 Diagnostix Plus
  • 8.5.3 MedAxiom
  • 8.5.4 MediNuclear Corporation (MNC)
  • 8.5.5 MEDX
  • 8.5.6 Pinestar Technology
  • 8.5.7 Technology Imaging Services
• 8.6 Other Business Opportunities

9. Other Elements of Nuclear Medicine Industry

• 9.1 Nuclear Medicine: Guidelines, Certification and Societies
  • 9.1.1 American College of Radiology (ACR)
  • 9.1.2 American Society of Nuclear Cardiology (ASNC)
  • 9.1.3 Associates in Medical Physics (AMP)
  • 9.1.4 Certification Board of Nuclear Cardiology (CBNC)
  • 9.1.5 ICANL
  • 9.1.6 IHE
  • 9.1.7 ISO
  • 9.1.8 MedPage Today
  • 9.1.9 Nuclear Medicine Technology Certification Board (NMTCB)
  • 9.1.10 Society of Cardiovascular Computed Tomography (SCCT)
  • 9.1.11 Society of Nuclear Medicine (SNM)
• 9.2 Nuclear Medicine: Publications
  • 9.2.1 Elsevier
  • 9.2.2 HRA Research
  • 9.2.3 Lippincott Williams & Wilkins

INDEX OF FIGURES

• Figure 3.1: U.S. Nuclear Imaging Procedures
• Figure 3.2: Digirad--Growth of Nuclear Imaging Procedures, 2004-2006
• Figure 4.1: Nuclear Imaging
• Figure 4.2: PET Scan
• Figure 4.3: SPECT Scan
• Figure 4.4: PET-CT Scan
• Figure 4.5: SPECT-CT Scan
• Figure 7.1: IHE Technical Framework
• Figure 7.2: IHE Framework Organization
• Figure 7.3: IHE Actors and Transactions

INDEX OF TABLES

• Table 2.1: U.S. Medical Imaging Market Size, 2001-2010
• Table 2.2: Global Medical Imaging Market Size, 2001-2010
• Table 2.3: U.S. Health Expenditures as a Percentage of GDP, 2000-2010
• Table 2.4: U.S. User Expenditures for Medical Imaging Equipment and Related Products
• Table 2.5: Millions of Americans Over 65 Years of Age, 2000-2050
• Table 2.6: Hospital Survey
• Table 2.7: Percent Change in Volume of Examinations per Imaging Modality, 1993-2004
• Table 2.8: Worldwide Market Share of Medical Imaging Companies
• Table 2.9: Worldwide Imaging Procedures, 2001 to 2010
• Table 2.10: Data Sources for Nuclear Medicine Professionals and Facilities
• Table 7.1: Market Share of Contrast Media Players
• Table 7.2: Contrast Media Market Growth, 2003-2010
• Table 7.3: Worldwide Imaging Procedures, 2001-2010
• Table 8.1: Astellas Alliances